Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,610 | 4,860 | 4,830 | 6,290 | 8,020 |
| Other current assets | 1,440 | 1,320 | 1,310 | 990 | 1,310 |
| TOTAL | $5,050 | $6,180 | $6,140 | $7,280 | $9,330 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 3,530 | 4,907 | 4,767 | 4,667 | 4,567 |
| TOTAL | $3,530 | $4,907 | $4,767 | $4,667 | $4,567 |
| Total Assets | $8,590 | $11,090 | $10,910 | $11,950 | $13,910 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 560 | 510 | 620 | 490 | 550 |
| Accrued Expenses | 500 | 520 | 370 | 740 | 570 |
| Other current liabilities | 0 | 2 | 4 | 6 | 0 |
| TOTAL | $3,260 | $3,220 | $3,190 | $3,430 | $3,320 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 810 | 960 | 1,000 | 1,300 | 2,590 |
| TOTAL | $810 | $960 | $1,000 | $1,300 | $2,598 |
| Total Liabilities | $4,070 | $4,190 | $4,190 | $4,740 | $5,930 |
| Shareholders' Equity | |||||
| Common Shares | 770 | 750 | 690 | 640 | 500 |
| Retained earnings | -60,740 | -57,790 | -55,670 | -53,860 | -50,840 |
| Other shareholders' equity | 0 | 0 | -10 | 0 | 0 |
| TOTAL | $4,510 | $6,890 | $6,710 | $7,210 | $7,980 |
| Total Liabilities And Equity | $8,580 | $11,080 | $10,900 | $11,950 | $13,910 |